• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者的残余肾功能:其重要性及其对改善患者预后的贡献。

Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.

机构信息

Division of Nephrology, Department of Medicine, The University of Mississippi Medical Center, Jackson, MS 39216, USA.

Renal Research Institute, New York, NY 10065, USA.

出版信息

Toxins (Basel). 2024 Jun 28;16(7):298. doi: 10.3390/toxins16070298.

DOI:10.3390/toxins16070298
PMID:39057938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11281084/
Abstract

Individuals afflicted with advanced kidney dysfunction who require dialysis for medical management exhibit different degrees of native kidney function, called residual kidney function (RKF), ranging from nil to appreciable levels. The primary focus of this manuscript is to delve into the concept of RKF, a pivotal yet under-represented topic in nephrology. To begin, we unpack the definition and intrinsic nature of RKF. We then juxtapose the efficiency of RKF against that of hemodialysis in preserving homeostatic equilibrium and facilitating physiological functions. Given the complex interplay of RKF and overall patient health, we shed light on the extent of its influence on patient outcomes, particularly in those living with advanced kidney dysfunction and on dialysis. This manuscript subsequently presents methodologies and measures to assess RKF, concluding with the potential benefits of targeted interventions aimed at preserving RKF.

摘要

患有晚期肾功能衰竭并需要透析治疗的患者表现出不同程度的原生肾功能,称为残余肾功能(RKF),范围从几乎没有到相当可观。本文的主要重点是深入探讨 RKF 的概念,这是肾脏病学中一个重要但未得到充分重视的话题。首先,我们剖析 RKF 的定义和内在性质。然后,我们将 RKF 的效率与血液透析在维持体内平衡和促进生理功能方面的效率进行对比。鉴于 RKF 与整体患者健康之间的复杂相互作用,我们阐明了它对患者结局的影响程度,特别是在那些患有晚期肾功能衰竭并接受透析治疗的患者中。本文随后介绍了评估 RKF 的方法和措施,最后介绍了旨在保护 RKF 的靶向干预措施的潜在益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2173/11281084/6b3c0c0802e8/toxins-16-00298-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2173/11281084/e1250a2812e1/toxins-16-00298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2173/11281084/6b3c0c0802e8/toxins-16-00298-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2173/11281084/e1250a2812e1/toxins-16-00298-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2173/11281084/6b3c0c0802e8/toxins-16-00298-g002.jpg

相似文献

1
Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.血液透析患者的残余肾功能:其重要性及其对改善患者预后的贡献。
Toxins (Basel). 2024 Jun 28;16(7):298. doi: 10.3390/toxins16070298.
2
Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology.个体化血液透析治疗:肾脏病学中残余肾功能与精准医学的视角。
Cardiorenal Med. 2019;9(2):69-82. doi: 10.1159/000494808. Epub 2018 Dec 11.
3
Preservation of residual kidney function in hemodialysis patients: reviving an old concept.维持血液透析患者的残余肾功能:重拾一个古老的概念。
Kidney Int. 2016 Aug;90(2):262-271. doi: 10.1016/j.kint.2016.02.037. Epub 2016 May 12.
4
Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling.增量血液透析准备好再次登场了吗?从经验主义到动力学建模。
J Nephrol. 2017 Aug;30(4):521-529. doi: 10.1007/s40620-017-0391-0. Epub 2017 Mar 23.
5
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险:一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
6
Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.透析患者保留残余肾功能的理由和策略。
Am J Nephrol. 2019;50(6):411-421. doi: 10.1159/000503805. Epub 2019 Oct 18.
7
Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?增量透析以保留残余肾功能——开始透析时是否有一种通用的方法?
Semin Dial. 2018 Jul;31(4):343-352. doi: 10.1111/sdi.12701. Epub 2018 May 7.
8
A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function.一项评估增量与常规起始血液透析对残余肾功能影响的多中心可行性随机对照试验。
Kidney Int. 2022 Mar;101(3):615-625. doi: 10.1016/j.kint.2021.07.025. Epub 2021 Aug 19.
9
What Is Known and Unknown About Twice-Weekly Hemodialysis.关于每周两次血液透析的已知与未知情况
Blood Purif. 2015;40(4):298-305. doi: 10.1159/000441577. Epub 2015 Nov 17.
10
Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.“临床可忽略”残余肾功能对尿毒症溶质清除的贡献。
Nephrol Dial Transplant. 2020 May 1;35(5):846-853. doi: 10.1093/ndt/gfz042.

引用本文的文献

1
Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins.在无尿血液透析患者中使用袢利尿剂清除蛋白结合型尿毒症毒素。
Clin Kidney J. 2025 Jun 14;18(7):sfaf195. doi: 10.1093/ckj/sfaf195. eCollection 2025 Jul.
2
Preservation of Residual Kidney Function in the Management of Patients on Incident Hemodialysis: An Opportunity to Improve Outcomes.初次血液透析患者管理中残余肾功能的保留:改善预后的契机。
Kidney360. 2025 Jan 1;6(1):12-14. doi: 10.34067/KID.0000000649.

本文引用的文献

1
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.钠-葡萄糖共转运蛋白 2 抑制剂与主要不良心血管结局:SMART-C 协作荟萃分析。
Circulation. 2024 Jun 4;149(23):1789-1801. doi: 10.1161/CIRCULATIONAHA.124.069568. Epub 2024 Apr 7.
2
Residual Kidney Function and Cause-Specific Mortality Among Incident Hemodialysis Patients.新入血液透析患者的残余肾功能与特定病因死亡率
Kidney Int Rep. 2023 Aug 3;8(10):1989-2000. doi: 10.1016/j.ekir.2023.07.020. eCollection 2023 Oct.
3
A Review of Residual Kidney Function in Peritoneal Dialysis Patients.
腹膜透析患者残余肾功能综述
Indian J Nephrol. 2023 Jul-Aug;33(4):239-246. doi: 10.4103/ijn.ijn_242_23. Epub 2023 Aug 16.
4
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease.慢性肾脏病中的肾脏脂质代谢紊乱和脂滴积累。
Nat Rev Nephrol. 2023 Oct;19(10):629-645. doi: 10.1038/s41581-023-00741-w. Epub 2023 Jul 27.
5
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.血液滤过或血液透析对肾衰竭死亡率的影响。
N Engl J Med. 2023 Aug 24;389(8):700-709. doi: 10.1056/NEJMoa2304820. Epub 2023 Jun 16.
6
Will SGLT2 Inhibitors Be Effective and Safe in Patients with Severe CKD, Dialysis, or Kidney Transplantation.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂对重度慢性肾脏病、透析或肾移植患者是否有效且安全?
Clin J Am Soc Nephrol. 2023 Nov 1;18(11):1500-1502. doi: 10.2215/CJN.0000000000000221. Epub 2023 Jun 14.
7
Mortality Risk of Patients Treated in Dialysis Facilities with Payment Reductions under ESRD Quality Incentive Program.接受 ESRD 质量激励计划下支付削减的透析设施治疗的患者的死亡率风险。
Clin J Am Soc Nephrol. 2023 Mar 1;18(3):356-362. doi: 10.2215/CJN.0000000000000079. Epub 2023 Feb 8.
8
Population-Based Limits of Urine Creatinine Excretion.基于人群的尿肌酐排泄限度
Kidney Int Rep. 2022 Aug 31;7(11):2474-2483. doi: 10.1016/j.ekir.2022.08.025. eCollection 2022 Nov.
9
Urine volume as an estimator of residual renal clearance and urinary removal of solutes in patients undergoing peritoneal dialysis.尿容量作为腹膜透析患者残余肾功能和溶质尿清除率的估计值。
Sci Rep. 2022 Nov 5;12(1):18755. doi: 10.1038/s41598-022-23093-0.
10
Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients.血清三甲胺 N-氧化物水平与晚期非透析慢性肾脏病患者的外周动脉僵硬度相关。
Toxins (Basel). 2022 Jul 31;14(8):526. doi: 10.3390/toxins14080526.